Abstract In this issue of Blood, Bartel and colleagues report the independent predictive value of the PET/CT and of the FDG suppression before transplantation in newly diagnosed myeloma patients who were treated using the TT3 regimen.1
Anna Galligan, Roslyn Wallace, Balasubramanian Krishnamurthy, Thomas W. H. Kay, Nirupa Sachithanandan, Cherie Chiang, Shahneen Sandhu, Rodney J. Hicks, Amir Iravani
María‐Victoria Mateos, Meletios A Dimopoulos, Michèle Cavo, Kenshi Suzuki, Andrzej Jakubowiak, Stefan Knop, Chantal Doyen, Paulo Lúcio, Zsolt Nagy, Polina Kaplan, Luděk Pour, Mark Cook, Sebastian Grosicki, Andre H Crepaldi, Anna Marina Liberati, Philip Campbell, Tatiana Shelekhova, Sung‐Soo Yoon, Genadi Iosava, Tomoaki Fujisaki, Mamta Garg, Christopher Chiu, Jianping Wang, Robin Carson, Wendy Crist, William Deraedt, Huong Nguyen, Ming Qi, Jesús F. San Miguel
Amir Iravani, Anna Galligan, Arian Lasocki, Roslyn Wallace, Alison M. Weppler, George Au Yeung, Tim Akhurst, Nirupa Sachithanandan, Cherie Chiang, Shahneen Sandhu, Rodney J. Hicks
Discussion(0)
No comments yet. Be the first to comment.